TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $944,000 | +0.4% | 8,160 | -14.3% | 0.04% | +6.1% |
| Q1 2018 | $940,000 | -15.2% | 9,519 | -10.0% | 0.03% | -15.4% |
| Q4 2017 | $1,108,000 | -9.9% | 10,579 | -3.1% | 0.04% | -11.4% |
| Q3 2017 | $1,230,000 | -47.1% | 10,918 | -47.3% | 0.04% | -48.2% |
| Q2 2017 | $2,323,000 | -3.6% | 20,733 | +0.4% | 0.08% | +1.2% |
| Q1 2017 | $2,409,000 | +42.5% | 20,656 | +28.6% | 0.08% | +31.2% |
| Q4 2016 | $1,691,000 | -1.7% | 16,060 | +3.2% | 0.06% | +10.3% |
| Q3 2016 | $1,720,000 | +8.5% | 15,561 | +42.9% | 0.06% | +45.0% |
| Q2 2016 | $1,585,000 | -0.8% | 10,887 | -2.3% | 0.04% | +5.3% |
| Q1 2016 | $1,597,000 | – | 11,147 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |